Allantoin

Basic Information

Item Value
DrugBank ID DB11100
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 29

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 severe nonproliferative diabetic retinopathy KG + DL
2 acrodermatitis chronica atrophicans KG + DL
3 neonatal dermatomyositis KG + DL
4 acne keloid KG + DL
5 secondary interstitial lung disease specific to childhood associated with a connective tissue disease KG + DL
6 amyopathic dermatomyositis KG + DL
7 hydroa vacciniforme, familial KG + DL
8 exanthem (disease) KG + DL
9 diabetic retinopathy KG + DL
10 bronchitis KG + DL
11 pityriasis lichenoides KG + DL
12 acute lichenoid pityriasis KG + DL
13 pustulosis palmaris et plantaris KG + DL
14 psoriasis 14, pustular KG + DL
15 pemphigus KG + DL
16 pemphigus vegetans KG + DL
17 vulvar inverted follicular keratosis KG + DL
18 acne (disease) KG + DL
19 uterine polyp KG + DL
20 anorectal stricture KG + DL
21 epulis KG + DL
22 polyp of middle ear KG + DL
23 polyp of vocal cord KG + DL
24 fibroepithelial polyp KG + DL
25 polyp of ureter KG + DL
26 polyp of frontal sinus KG + DL
27 polyp of vulva KG + DL
28 polyp of external auditory canal KG + DL
29 neoplastic polyp KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.